This week, Kirk Geale, PhD and Jessica Young represented Quantify Research at the 42nd ISPE Annual Meeting in Milan.
Jessica joined the faculty for Intermediate Pharmacoepidemiology: Addressing Unmeasured Confounding through Study Design and Analysis.
Kirk contributed to Tomorrow’s Evidence 2.0: Replace, Refine, or Reframe the Evidence Pyramid? A Live Framework Build.
Different topics, but a common question: how do we generate evidence that is both methodologically rigorous and useful for real-world decisions?
That question is central to our work at Quantify.
We support epidemiological and real-world evidence studies from research question and study design through analysis, interpretation and communication.
This includes navigating challenges such as confounding, appropriate use of real-world data, analytical design and the interpretation of evidence in context.
We were also pleased to be joined by our colleagues Fabienne Diaz Bazin and Clementine Lacueille from Horiana, as part of the wider athagoras Group presence at ISPE.
It was a valuable opportunity to exchange perspectives across teams and with the wider pharmacoepidemiology community.
How is your organisation approaching the methodological challenges behind increasingly complex real-world evidence studies?
